Lack of association of the S769N mutation in Plasmodium falciparum SERCA (PfATP6) with resistance to artemisinins.

Antimicrobial Agents and Chemotherapy
Long CuiLiwang Cui

Abstract

The recent emergence of artemisinin (ART) resistance in Plasmodium falciparum in western Cambodia, manifested as delayed parasite clearance, is a big threat to the long-term efficacy of this family of antimalarial drugs. Among the multiple candidate genes associated with ART resistance in P. falciparum, the sarcoplasmic/endoplasmic reticulum Ca(2+)-ATPase PfATP6 has been postulated as a specific target of ARTs. The PfATP6 gene harbors multiple single-nucleotide polymorphisms in field parasite populations, and S769N has been associated with decreased sensitivity to artemether in parasite populations from French Guiana. In this study, we used an allelic exchange strategy to engineer parasite lines carrying the S769N mutations in P. falciparum strain 3D7 and evaluated whether introduction of this mutation modulated parasite sensitivity to ART derivatives. Using three transgenic lines carrying the 769N mutation and two transgenic lines carrying the wild-type 769S as controls, we found that S769N did not affect PfATP6 gene expression. We compared the sensitivities of these parasite lines to three ART derivatives, artemether, artesunate, and dihydroartemisinin, in 18 biological experiments and detected no significant effect of the S7...Continue Reading

References

Jun 1, 1994·Transactions of the Royal Society of Tropical Medicine and Hygiene·S R Meshnick
May 1, 1993·Antimicrobial Agents and Chemotherapy·S R MeshnickY Yuthavong
Oct 6, 1997·Proceedings of the National Academy of Sciences of the United States of America·D A Fidock, T E Wellems
Feb 7, 2001·Biochemical Pharmacology·J CharoenteeraboonY Yuthavong
Jun 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·M B ReedA F Cowman
Nov 19, 2002·International Journal for Parasitology·Steven R Meshnick
Aug 22, 2003·Nature·U Eckstein-LudwigS Krishna
Apr 24, 2004·Antimicrobial Agents and Chemotherapy·Martin SmilksteinMichael Riscoe
Aug 25, 2004·Science·Cally RoperTim Anderson
Nov 10, 2004·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Sanjeev KrishnaRichard K Haynes
Jun 7, 2005·Nature Structural & Molecular Biology·Anne-Catrin UhlemannSanjeev Krishna
Apr 18, 2006·Trends in Molecular Medicine·Sanjeev KrishnaOdile Mercereau-Puijalon
Feb 8, 2007·Emerging Infectious Diseases·Sandrine CojeanRémy Durand
Mar 25, 2008·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Sabina DahlströmJosé Pedro Gil
Apr 19, 2008·Science·N J White
Jul 9, 2008·Malaria Journal·Guoqing ZhangLinhua Tang
Dec 10, 2008·The New England Journal of Medicine·Harald NoedlUNKNOWN Artemisinin Resistance in Cambodia 1 (ARC1) Study Consortium
Feb 20, 2009·Malaria Journal·Maman Laminou IbrahimJean-Bernard Duchemin
Jul 31, 2009·The New England Journal of Medicine·Arjen M DondorpNicholas J White
Oct 7, 2009·Expert Review of Anti-infective Therapy·Liwang Cui, Xin-zhuan Su
Feb 18, 2010·Antimicrobial Agents and Chemotherapy·Benoit WitkowskiFrançoise Benoit-Vical
Mar 26, 2010·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Paul M O'NeillStephen A Ward
Mar 31, 2010·Antimicrobial Agents and Chemotherapy·Marina ChavchichDennis E Kyle
Apr 28, 2010·Antimicrobial Agents and Chemotherapy·Mallika ImwongNicholas J White
May 13, 2010·Journal of Molecular Modeling·Pradeep Kumar NaikHarvinder Singh
May 21, 2010·PLoS Pathogens·Stephanie G ValderramosDavid A Fidock
Jul 20, 2010·Trends in Parasitology·Sanjeev KrishnaHenry Staines
Sep 25, 2010·The Journal of Infectious Diseases·François Nosten
Sep 30, 2010·Emerging Infectious Diseases·Dea ShahinasDylan R Pillai

❮ Previous
Next ❯

Citations

Nov 26, 2013·Trends in Pharmacological Sciences·Sanjeev KrishnaHenry M Staines
Nov 7, 2013·Advances in Colloid and Interface Science·N P AdityaE B Souto
Jan 18, 2013·Molecular & Cellular Proteomics : MCP·Scott E LindnerStefan H I Kappe
Jul 21, 2012·Molecular Microbiology·Long CuiLiwang Cui
Aug 1, 2013·Molecular Microbiology·Philip J Rosenthal
Jul 24, 2013·Critical Reviews in Toxicology·M Helena R AmorimMargarida M S M Bastos
Feb 4, 2015·The American Journal of Tropical Medicine and Hygiene·Tamar E CarterBernard A Okech
Feb 8, 2020·Journal of Medicinal Chemistry·Lucie PeterkováSilvie Rimpelová
Apr 15, 2021·Medicinal Research Reviews·Yash GuptaPrakasha Kempaiah

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.